{"id":19430,"date":"2022-03-09T15:46:55","date_gmt":"2022-03-09T15:46:55","guid":{"rendered":"https:\/\/zeepedia.com\/?p=19430"},"modified":"2022-03-11T12:40:24","modified_gmt":"2022-03-11T12:40:24","slug":"obizur","status":"publish","type":"post","link":"https:\/\/zeepedia.com\/medical\/medicines\/obizur\/","title":{"rendered":"OBIZUR &#8211; Susoktokog alfa uses, dose and side effects"},"content":{"rendered":"\n<p>500 U powder and solvent for solution for injection<br>susoktokog alfa<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">What OBIZUR is and what it is used for<\/h2>\n\n\n\n<p>OBIZUR contains the active substance susoktokog alfa, anti-\u00a0hemophilia\u00a0factor VIII, porcine sequence.\u00a0Factor VIII is needed for the blood to coagulate and stop bleeding.<\/p>\n\n\n\n<p>In patients with acquired\u00a0hemophilia,\u00a0factor VIII\u00a0does not work properly because the patient has developed\u00a0antibodies\u00a0to their factor VIII that neutralize this blood coagulation factor.<\/p>\n\n\n\n<p>OBIZUR is used to treat bleeding in adults with acquired\u00a0hemophilia\u00a0(a bleeding disorder caused by a lack of factor VIII activity due to the development of\u00a0antibodies\u00a0).\u00a0These\u00a0antibodies\u00a0have a less neutralizing effect against OBIZUR than against human factor VIII.<\/p>\n\n\n\n<p>OBIZUR restores the missing factor VIII activity and helps the blood to coagulate at the bleeding site.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">What you need to know before you are given OBIZUR<\/h2>\n\n\n\n<h2 class=\"wp-block-heading\">You must not be given OBIZUR:<\/h2>\n\n\n\n<ul class=\"wp-block-list\"><li>if you are allergic to susoktokog alfa or any of the other ingredients of this medicine (listed in section 6)<\/li><li>if you are allergic to hamster protein (trace amounts may occur in OBIZUR due to the manufacturing process).<\/li><\/ul>\n\n\n\n<p>If you are not sure, talk to your doctor before taking this medicine.<\/p>\n\n\n\n<p>This medicine is only to be given to patients in a hospital.\u00a0It requires monitoring of the patient&#8217;s bleeding status.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Warnings and cautions<\/h2>\n\n\n\n<p>Talk to your doctor before giving OBIZUR.<\/p>\n\n\n\n<p>Hypersensitivity<\/p>\n\n\n\n<p>There is a small risk that you may have an&nbsp;allergic reaction&nbsp;to OBIZUR.&nbsp;You should be aware of the early signs of allergic reactions (signs and symptoms can be found in section 4).&nbsp;If any of these symptoms occur, the&nbsp;injection&nbsp;should be stopped.&nbsp;Serious symptoms, including difficulty breathing and (almost) fainting, require&nbsp;urgent&nbsp;hospital treatment.<\/p>\n\n\n\n<p>Inhibitors<\/p>\n\n\n\n<p>Your doctor may check if you have inhibitory&nbsp;antibodies&nbsp;to porcine factor VIII<\/p>\n\n\n\n<p>and if these&nbsp;antibodies&nbsp;are increasing.<\/p>\n\n\n\n<p>Your doctor will check the presence of factor VIII in your blood to confirm that you have had enough factor VIII.&nbsp;The doctor will also check if the bleeding is under satisfactory control.<\/p>\n\n\n\n<p>Cardiovascular events<\/p>\n\n\n\n<p>Talk to your doctor if you currently have or have had cardiovascular disease or if you have a known risk of&nbsp;thrombosis&nbsp;(a disease caused by blood clots in the blood vessels), as the risk of developing blood clot-related diseases at high and persistent factor VIII levels cannot be ruled out.<\/p>\n\n\n\n<p><strong><em><strong>Children&nbsp;<\/strong><strong>and&nbsp;<\/strong><strong>young people<\/strong><\/em><\/strong><\/p>\n\n\n\n<p>There is no information on the use of OBIZUR in children and adolescents under 18 years of age.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Other medicines and OBIZUR<\/h2>\n\n\n\n<p>Tell your doctor if you are taking, have recently taken, or might take any other medicines.\u00a0No\u00a0interaction\u00a0between OBIZUR and other drugs is known.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Pregnancy and breastfeeding<\/h2>\n\n\n\n<p>If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor for advice before using this medicine.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Driving and using machines<\/h2>\n\n\n\n<p>OBIZUR does not affect the ability to drive and use machines.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">OBIZUR contains sodium<\/h2>\n\n\n\n<p>After\u00a0reconstitution, this medicinal product contains 4.6 mg\u00a0sodium\u00a0(the main ingredient in table salt\/table salt) per milliliter.\u00a0This corresponds to 0.23% of the maximum recommended daily\u00a0sodium\u00a0intake for adults.\u00a0Several vials must be taken per\u00a0dose.<\/p>\n\n\n\n<p>Tell your doctor if you have been prescribed a low-salt diet.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">How OBIZUR is given<\/h2>\n\n\n\n<p>The treatment with OBIZUR is carried out by a doctor who has experience in caring for patients with\u00a0hemophilia\u00a0(bleeding disorders).<\/p>\n\n\n\n<p>Your doctor will calculate your\u00a0dose\u00a0of OBIZUR (in units or E) depending on your condition and your body weight.\u00a0How often and for how long you receive treatment depends on how well OBIZUR works for you.\u00a0In most cases, replacement therapy with OBIZUR is a temporary treatment until the bleeding has stopped or the\u00a0antibodies\u00a0to your factor VIII have been removed.<\/p>\n\n\n\n<p>Your doctor will check for the presence of&nbsp;antibodies&nbsp;to OBIZUR.<\/p>\n\n\n\n<p>The recommended starting dose is 200 U per kilogram body weight, given as an\u00a0intravenous\u00a0injection.<\/p>\n\n\n\n<p>Your doctor will measure your factor VIII activity regularly to determine the next&nbsp;dose&nbsp;and how often you should receive OBIZUR.<\/p>\n\n\n\n<p>The bleeding usually responds within the first 24 hours.&nbsp;Your doctor will adjust the&nbsp;dose&nbsp;one and the duration of OBIZUR until the bleeding has stopped.<\/p>\n\n\n\n<p>The full volume of reconstituted (reconstituted) OBIZUR should be given at a rate of 1 to 2 ml per minute.<\/p>\n\n\n\n<p>If you have any further questions on the use of this product, ask your doctor.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Possible side effects<\/h2>\n\n\n\n<p>Like all medicines, this medicine can cause\u00a0side effects, although not everybody gets them.<\/p>\n\n\n\n<p>In the event of a severe and sudden\u00a0allergic reaction,\u00a0injection\u00a0must\u00a0be stopped immediately.\u00a0If any of the following early symptoms occur, you must contact a doctor immediately:<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>Swelling of lips and tongue<\/li><li>A burning and stinging sensation at the injection site<\/li><li>Chills,&nbsp;redness<\/li><li>Rash, general&nbsp;itching<\/li><li>Headache, low&nbsp;blood pressure<\/li><li>Numbness, malaise, restlessness<\/li><li>Fast heartbeat, pressure over the chest<\/li><li>Irritations, vomiting<\/li><li>Wheezing<\/li><\/ul>\n\n\n\n<p><strong>Very common&nbsp;side effects&nbsp;(may affect more than 1 in 10 people)<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>Development of&nbsp;antibodies&nbsp;and increase of existing&nbsp;antibodies&nbsp;to the drug, which may lead to a lack of effect with continued bleeding.<\/li><\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">How to store OBIZUR<\/h2>\n\n\n\n<p>Keep this medicine out of the sight and reach of children.<\/p>\n\n\n\n<p>Do not use this medicine after the expiry date which is stated on the carton, vial, and prefilled syringe after EXP.\u00a0The expiration date is the last day of the specified month.<\/p>\n\n\n\n<p>Store in a refrigerator (2 \u00b0 C \u2011 8 \u00b0 C).<\/p>\n\n\n\n<p>Do not freeze.<\/p>\n\n\n\n<p>The reconstituted solution should be used immediately, but no later than 3 hours after the powder has completely dissolved.<\/p>\n\n\n\n<p>After\u00a0reconstitution, the solution should be clear and colorless.<\/p>\n\n\n\n<p>Do not administer&nbsp;it if there are particles or discoloration.<\/p>\n\n\n\n<p>As this medicine is used during a hospital stay, the hospital staff is responsible for the proper storage of this medicine before and during its use, as well as for proper disposal.<\/p>\n\n\n\n<p>Name and batch number<\/p>\n\n\n\n<p>It is strongly recommended that each time OBIZUR is administered to a patient, the name and manufacturing batch number of the medicinal product should be noted so that a link between the patient and the manufacturing batch number of the medicinal product can be maintained.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Contents of the pack and other information<\/h2>\n\n\n\n<h2 class=\"wp-block-heading\">Content declaration<\/h2>\n\n\n\n<ul class=\"wp-block-list\"><li>The active substance is susoktokog alfa (anti-&nbsp;hemophilia&nbsp;factor VIII, porcine sequence, produced by&nbsp;recombinant DNA&nbsp;technology).&nbsp;Each powder&nbsp;vial&nbsp;contains 500 U susoktokog alfa.<\/li><li>The other ingredients in the powder are polysorbate 80, sodium chloride (see also section 2), calcium chloride dihydrate, sucrose, <a href=\"https:\/\/zeepedia.com\/medical\/medicines\/tribonate\/\">trometamol<\/a>, trometamol hydrochloride, sodium citrate.<\/li><li>The solvent is 1 ml of sterile water for injections.<\/li><\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">What the medicine looks like and contents of the pack<\/h2>\n\n\n\n<p>A package contains 1, 5, or 10 of the following:<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>glass vial&nbsp;with 500 U OBIZUR, a white, brittle powder, with butyl rubber stopper coated with FluroTec&nbsp;<sup>\u00ae<\/sup>&nbsp;and detachable seal<\/li><li>pre-filled glass syringe with bromobutyl rubber stopper coated with FluroTec&nbsp;<sup>\u00ae<\/sup>&nbsp;foil on contact side with 1 ml sterile water for injections with bromobutyl rubber needle guard and Luer cap adapter<\/li><li>liquid transfer device with built-in plastic tip<\/li><\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Marketing Authorisation Holder<\/h2>\n\n\n\n<p>Baxalta Innovations GmbH<\/p>\n\n\n\n<p>Industriestrasse 67<\/p>\n\n\n\n<p>1221 Vienna<\/p>\n\n\n\n<p>AUSTRIA<\/p>\n\n\n\n<p>Tel: +80066838470<\/p>\n\n\n\n<p>Email: medinfoEMEA@shire.com<\/p>\n\n\n\n<p><strong>Manufacturer<\/strong><\/p>\n\n\n\n<p>Takeda Manufacturing Austria AG<\/p>\n\n\n\n<p>Industriestrasse 67<\/p>\n\n\n\n<p>1221 Vienna<\/p>\n\n\n\n<p>AUSTRIA<\/p>\n\n\n\n<p>Baxter AG<\/p>\n\n\n\n<p>Industriestrasse 67<\/p>\n\n\n\n<p>1221 Vienna<\/p>\n\n\n\n<p>AUSTRIA<\/p>\n\n\n\n<p>This medicine has been authorized following the rules of &#8220;exceptional authorization&#8221;.\u00a0This means that it has not been possible to obtain complete information about this medicine as the disease is rare.<\/p>\n\n\n\n<p>Every year, the European Medicines Agency reviews any new information and updates this leaflet as needed.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>OBIZUR contains the active substance susoktokog alfa, anti- haemophilia factor VIII, porcine sequence. Factor VIII is needed for the blood to coagulate and stop bleeding.<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"cybocfi_hide_featured_image":"","footnotes":""},"categories":[2200,18526],"tags":[19504,19499,19500,19503,19495,19498,19501,19496,19502,19497],"class_list":["post-19430","post","type-post","status-publish","format-standard","hentry","category-medicines","category-o","tag-benefits-of-obizu","tag-benefits-of-susoktokog-alfa","tag-obizu","tag-obizu-side-effects","tag-susoktokog-alfa","tag-susoktokog-alfa-side-effects","tag-what-is-obizu","tag-what-is-susoktokog-alfa","tag-what-obizu-is-used-for","tag-what-susoktokog-alfa-is-used-for"],"_links":{"self":[{"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/posts\/19430","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/comments?post=19430"}],"version-history":[{"count":4,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/posts\/19430\/revisions"}],"predecessor-version":[{"id":19459,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/posts\/19430\/revisions\/19459"}],"wp:attachment":[{"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/media?parent=19430"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/categories?post=19430"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/tags?post=19430"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}